1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
Delayed London Stock Exchange  -  05/20 11:36:48 am EDT
1764.00 GBX   +1.87%
05/20Deutsche Bank Keeps GSK At Hold, Boosts PT
MT
05/19GLAXOSMITHKLINE : Deutsche Bank remains Neutral
MD
05/19GLAXOSMITHKLINE PLC : Ex-dividend day for interim dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GSK Ventures into Bioelectronic Therapies For Arthritis With Study Launches

01/26/2022 | 10:16pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. -1.34% 2178.16 Delayed Quote.-24.81%
GLAXOSMITHKLINE PLC 1.87% 1764 Delayed Quote.9.80%
All news about GLAXOSMITHKLINE PLC
05/20Deutsche Bank Keeps GSK At Hold, Boosts PT
MT
05/19GLAXOSMITHKLINE : Deutsche Bank remains Neutral
MD
05/19GLAXOSMITHKLINE PLC : Ex-dividend day for interim dividend
FA
05/18S&P Maintains GSK's Ratings, Stable Outlook on Expected Post-Demerger Recovery
MT
05/17FTSE 100 lags European peers on strong pound
RE
05/17GlaxoSmithKline Pharmaceuticals Sees Surge in Fiscal Q4 Consolidated Net Profit
MT
05/16Glaxosmithkline Confirms It Has Changed Its Name To GSK PLC
RE
05/16GlaxoSmithKline Adopts Shortened GSK Name
MT
05/16GlaxoSmithKline plc has Changed its Name to GSK plc
CI
05/16SocGen Lifts GlaxoSmithKline's PT, Keeps Buy Rating
MT
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2022 36 543 M 45 551 M 45 551 M
Net income 2022 5 289 M 6 593 M 6 593 M
Net Debt 2022 17 655 M 22 006 M 22 006 M
P/E ratio 2022 16,6x
Yield 2022 2,98%
Capitalization 89 279 M 111 B 111 B
EV / Sales 2022 2,93x
EV / Sales 2023 2,78x
Nbr of Employees 90 096
Free-Float 93,6%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 1 764,00 GBX
Average target price 1 865,77 GBX
Spread / Average Target 5,77%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis VP & Head-Technology Business Development
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC9.80%111 286
JOHNSON & JOHNSON1.68%465 705
PFIZER, INC.-11.14%294 404
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707